Delivery Order SPE2DB20D1051-SPE2DB25FD9GM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,004.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,046.17 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of August 22, 2025. This is a firm fixed price, non-set-aside contract awarded competitively on August 21, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,712.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents with a ceiling value of $1,179.61 under a firm fixed price contract. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's headquarters location in...
- The Defense Logistics Agency awarded a $4,004.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This non-competitive delivery order, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,004.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price delivery order, issued on August 20, 2025, represents a pediatric or adult pharmaceutical supply requirement with an ultimate completion date of August 21, 2025. The contract was awarded on a competitive basis without set-aside designation, with performance to be fulfilled at AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $4,004.68 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance based in Conshohocken, Pennsylvania and completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,001.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents, with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award demonstrates continued federal reliance on AmerisourceBergen as a critical pharmaceutical distributor for military...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9GMDelivery Order
The Defense Logistics Agency (DLA) awarded a $4,004.68 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vivitrol 380 mg vials with diluents. This firm fixed-price contract, designated as a non-competitive award with no set-aside designation, has an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The Vivitrol order fulfills DLA's need for opioid dependence treatment medications within its Medical Supply Chain. This delivery order exemplifies the company's role as a prime vendor under the comprehensive DLA pharmaceutical support vehicle, which enables supply of specialized medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/3/25 |